MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,165K
Free Cash flow
-$2,643K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Amortization - intangible assets
Securities matured
Accrued expenses and other curre...
Others
Negative Cash Flow Breakdown
Net loss
Trade receivables
Acquisition of intangibles
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-3,765
-4,534
-4,530
-6,121
Depreciation
526
519
519
506
Amortization - intangible assets
1,317
1,372
1,397
1,394
Impairment loss
-
-
0
0
Loss on disposal of property and equipment
-2
-15
-25
-36
Stock-based compensation
69
643
727
867
Noncash portion of rent benefit
-17
-13
-11
-10
Accretion/amortization of available-for-sale securities
76
105
105
141
Equity in loss of nonconsolidated entities
-44
-25
-48
-13
Deferred tax expense
4
18
-269
-47
Purchased inventory
159
347
-3
-121
Prepaid expenses and deposits
-177
39
-635
468
Trade receivables
1,242
1,416
-131
847
Other receivables
-84
-94
-133
-192
Accounts payable
-647
385
55
-420
Accrued income tax
17
-53
63
-58
Accrued expenses and other current liabilities
1,095
-1,796
268
321
Customer contract liabilities
32
25
11
-8
Other liabilities
-12
-50
1
10
Net cash used in operating activities
-2,551
-5,257
-899
-4,660
Securities matured
-1,202
-6,135
-2,636
-4,185
Investment in property and equipment
92
60
107
43
Acquisition of intangibles
724
453
80
101
Net cash provided by investing activities
386
5,622
2,449
4,041
(decrease) increase in cash and cash equivalents
-2,165
365
1,550
-619
Effect of exchange rate changes on cash
-10
-13
-29
99
Cash and cash equivalents, beginning of year
9,369
9,017
7,496
7,021
Cash and cash equivalents, end of period
7,194
9,369
9,017
7,496
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Securities matured
-$1,202K
(91.23%↑ Y/Y)
Net cash provided by
investing activities
$386K
(-97.05%↓ Y/Y)
Canceled cashflow
$816K
(decrease) increase in cash
and cash...
-$2,165K
(-317.59%↓ Y/Y)
Canceled cashflow
$386K
Amortization - intangible
assets
$1,317K
(-57.58%↓ Y/Y)
Accrued expenses and
other current...
$1,095K
(169.39%↑ Y/Y)
Depreciation
$526K
(-48.93%↓ Y/Y)
Prepaid expenses and
deposits
-$177K
(52.55%↑ Y/Y)
Other receivables
-$84K
(51.72%↑ Y/Y)
Stock-based compensation
$69K
(-92.14%↓ Y/Y)
Equity in loss of
nonconsolidated entities
-$44K
(45.00%↑ Y/Y)
Customer contract
liabilities
$32K
(-31.91%↓ Y/Y)
Accrued income tax
$17K
(312.50%↑ Y/Y)
Deferred tax expense
$4K
(103.57%↑ Y/Y)
Loss on disposal of
property and equipment
-$2K
(71.43%↑ Y/Y)
Acquisition of intangibles
$724K
(265.66%↑ Y/Y)
Investment in property and
equipment
$92K
(-77.94%↓ Y/Y)
Net cash used in
operating activities
-$2,551K
(78.90%↑ Y/Y)
Canceled cashflow
$3,367K
Net loss
-$3,765K
(94.71%↑ Y/Y)
Trade receivables
$1,242K
(1085.71%↑ Y/Y)
Accounts payable
-$647K
(-335.27%↓ Y/Y)
Purchased inventory
$159K
(-76.34%↓ Y/Y)
Accretion/amortization of
available-for-sale securities
$76K
(-84.03%↓ Y/Y)
Noncash portion of rent
benefit
-$17K
(19.05%↑ Y/Y)
Other liabilities
-$12K
(-121.43%↓ Y/Y)
Buy us a coffee
Zomedica Corp. (ZOMDF)
Zomedica Corp. (ZOMDF)